Skip to main content

Find Clinical Trials

Home
Conditions
Mosquito-Borne Diseases

Clinical trial condition

Mosquito-Borne Diseases

Explore clinical trials studying Mosquito-Borne Diseases. Study availability and eligibility vary by location and protocol.

1,584 public trials 85 recruiting studies

Refine in advanced search Browse all conditions

Mosquito-Borne Diseases trial results

Completed

Immune Response to Different Schedules of a Tetravalent Dengue Vaccine Given With or Without Yellow Fever Vaccine

NCT01488890

Conditions: Arbovirus Infections, Dengue, Dengue Fever, +11 more
Locations: Alabaster, Alabama, United States

Sacramento, California, United States

Jacksonville, Florida, United States

Silver Spring, Maryland, United States

View Trial Details

Completed

Immunogenicity and Safety of Sanofi Pasteur's CYD Dengue Vaccine in Healthy Children and Adolescents in Latin America

NCT00993447

Conditions: Arbovirus Infections, Dengue, Dengue Fever, +11 more
Locations: Bucaramanga, Colombia

Tegucigalpa, Honduras

Cuernavaca, Mexico

San Juan, Puerto Rico

View Trial Details

Completed

Study of a Booster Dose of a Tetravalent Dengue Vaccine in Subjects Who Previously Completed the 3-dose Schedule

NCT02623725

Conditions: Arbovirus Infections, Dengue, Dengue Fever, +10 more
Locations: Investigational Site Number 001 Vitória, Brazil

Investigational Site Number 002 Bucaramanga, Colombia

Investigational Site Number 003 Tegucigalpa, Honduras

Investigational Site Number 004 Temixco, Mexico

View Trial Details

Completed

Immunogenicity and Safety of Different Vaccination Schedules of Tetravalent Dengue Vaccine in Healthy Subjects 9 to 50 Years of Age

NCT02628444

Conditions: Arbovirus Infections, Dengue, Dengue Fever, +10 more
Locations: Investigational Site 102 Barranquilla, Colombia

Investigational Site 101 Cali, Colombia

Investigational Site 103 Medellín, Colombia

Investigational Primary Site Muntinlupa 201_Satellite Site San Pablo 202 City of Muntinlupa, Philippines

View Trial Details

Completed

Immunogenicity and Safety of a Tetravalent Dengue Vaccine Booster Injection in Subjects Who Previously Completed a 3-dose Schedule

NCT02824198

Conditions: Arbovirus Infections, Dengue, Dengue Fever, +10 more
Locations: Singapore

Singapore

Singapore

View Trial Details

Completed

Immunologic Mechanisms of Immune Interference and/or Cross-Neutralizing Immunity After CYD Tetravalent Dengue Vaccine

NCT01943825

Conditions: Arbovirus Infections, Dengue, Dengue Fever, +10 more
Locations: Syracuse, New York, United States

View Trial Details

Completed

Very Severe Malaria Treated by Intravenous Artesunate

NCT04516317

Conditions: Infections, Malaria, Mosquito-Borne Diseases, +4 more
Locations: Fabrice BRUNEEL Le Chesnay, Île-de-France Region, France

View Trial Details

Completed

Research Study to Assess New Chikungunya and Zika Vaccines in Healthy Adults in Mexico.

NCT04440774

Conditions: Alphavirus Infections, Arbovirus Infections, Chikungunya, +11 more
Locations: Hospital Universitario "Dr. José Eleuterio González" de la Universidad Autónoma de Nuevo León. Monterrey, Nuevo León, Mexico

View Trial Details

Completed

Study of Sanofi Pasteur's CYD Dengue Vaccine in Healthy Subjects in Singapore

NCT00880893

Conditions: Arbovirus Infections, Dengue, Dengue Diseases, +12 more
Locations: Singapore

Singapore

Singapore

Singapore

View Trial Details

Completed

Study of a Novel Tetravalent Dengue Vaccine in Healthy Children and Adolescents Aged 9 to 16 Years in Latin America

NCT01374516

Conditions: Arbovirus Infections, Dengue, Dengue Fever, +10 more
Locations: Fortaleza, Ceará, Brazil

Vitória, Espírito Santo, Brazil

Goiânia, Goiás, Brazil

Campo Grande, Mato Grosso do Sul, Brazil

View all 22 locations

View Trial Details